These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32582913)

  • 1. MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.
    Wang Q; Zhao D; Xian M; Wang Z; Bi E; Su P; Qian J; Ma X; Yang M; Liu L; Zu Y; Pingali SR; Chen K; Cai Z; Yi Q
    Blood; 2020 Nov; 136(22):2557-2573. PubMed ID: 32582913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13.
    Du T; Song Y; Ray A; Chauhan D; Anderson KC
    Leukemia; 2021 Feb; 35(2):550-561. PubMed ID: 32424294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance.
    Ge M; Qiao Z; Kong Y; Liang H; Sun Y; Lu H; Xu Z; Liu H
    Br J Cancer; 2021 Feb; 124(4):770-776. PubMed ID: 33250513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
    Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma.
    Xie Y; Liu J; Jiang H; Wang J; Li X; Wang J; Zhu S; Guo J; Li T; Zhong Y; Zhang Q; Liu Z
    Oncogene; 2020 Jan; 39(4):922-934. PubMed ID: 31576013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
    Leyton-Jaimes MF; Kahn J; Israelson A
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.
    Xu Y; Fulciniti M; Samur MK; Ho M; Deng S; Liu L; Wen K; Yu T; Chyra Z; Dereibal S; Zhang L; Yao Y; Chakraborty C; Morelli E; Li N; Lopez MA; Perini T; Mu S; An G; Alonso R; Bianchi G; Tai YT; Anderson KC; Qiu L; Munshi NC
    Blood; 2020 Jul; 136(4):468-479. PubMed ID: 32187357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
    Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
    Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
    Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
    Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
    Turner JG; Kashyap T; Dawson JL; Gomez J; Bauer AA; Grant S; Dai Y; Shain KH; Meads M; Landesman Y; Sullivan DM
    Oncotarget; 2016 Nov; 7(48):78896-78909. PubMed ID: 27806331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
    Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
    Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
    Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
    Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.
    Rafiei S; Gui B; Wu J; Liu XS; Kibel AS; Jia L
    Mol Cancer Res; 2019 Jan; 17(1):263-276. PubMed ID: 30224544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
    Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
    Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-Transmitted
    Xu H; Han H; Song S; Yi N; Qian C; Qiu Y; Zhou W; Hong Y; Zhuang W; Li Z; Li B; Zhuang W
    Clin Cancer Res; 2019 Mar; 25(6):1923-1935. PubMed ID: 30610101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
    Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
    Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
    Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
    J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.